The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation

Blood

Volumn 113, Issue 21, 2009, Pages 5323-5329

  Banno, Fumiaki ^a   Chauhan, Anil K ^b   Kokame, Koichi ^a   Yang, Jin ^a   Miyata, Shigeki ^a   Wagner, Denisa D ^b   Miyata, Toshiyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; COLLAGEN; FERRIC CHLORIDE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE; ADAMTS13 PROTEIN, MOUSE; FERRIC ION; METALLOPROTEINASE; VON WILLEBRAND FACTOR;

129 MOUSE; ADAMTS13 GENE; ANIMAL CELL; ARTICLE; C57BL 6 MOUSE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHEAR RATE; THROMBOCYTOPENIA; THROMBOGENESIS; ANIMAL; ARTERIOLE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; MOUSE STRAIN; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; THROMBOSIS;

ANIMALS; ARTERIOLES; FERRIC COMPOUNDS; METALLOENDOPEPTIDASES; MICE; MICE, INBRED STRAINS; PROTEIN STRUCTURE, TERTIARY; THROMBOCYTOPENIA; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 67149121187     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-07-169359     Document Type: Article

References (38)

1. Dong JF. Structural and functional correlation of ADAMTS13. Curr Opin Hematol. 2007;14:270-276.
2. Bergmeier W, Chauhan AK, Wagner DD. Glycoprotein Ibalpha and von Willebrand factor in primary platelet adhesion and thrombus formation: lessons from mutant mice. Thromb Haemost. 2008;99:264-270. (Pubitemid 351230954)
3. Tsai HM. Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency. Hematol Oncol Clin North Am. 2007;21:609-632.
4. Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol. 2008;3:249-277.
5. Desch KC, Motto DG. Thrombotic thrombocytopenic purpura in humans and mice. Arterioscler Thromb Vasc Biol. 2007;27:1901-1908. (Pubitemid 47312297)
6. Soejima K, Matsumoto M, Kokame K, et al. ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage. Blood. 2003;102:3232-3237. (Pubitemid 37314760)
7. Zheng X, Nishio K, Majerus EM, Sadler JE. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13. J Biol Chem. 2003;278:30136-30141. (Pubitemid 36962406)
8. Ai J, Smith P, Wang S, Zhang P, Zheng XL. The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor. J Biol Chem. 2005;280:29428-29434. (Pubitemid 41177015)
9. Majerus EM, Anderson PJ, Sadler JE. Binding of ADAMTS13 to von Willebrand factor. J Biol Chem. 2005;280:21773-21778. (Pubitemid 40827825)
10. Tao Z, Wang Y, Choi H, et al. Cleavage of ultralarge multimers of von Willebrand factor by C-terminal-truncated mutants of ADAMTS-13 under flow. Blood. 2005;106:141-143. (Pubitemid 40967185)
11. Tao Z, Peng Y, Nolasco L, et al. Recombinant CUB-1 domain polypeptide inhibits the cleavage of ULVWF strings by ADAMTS13 under flow conditions. Blood. 2005;106:4139-4145. (Pubitemid 41775919)
12. Gao W, Anderson PJ, Majerus EM, Tuley EA, Sadler JE. Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease. Proc Natl Acad Sci U S A. 2006;103:19099-19104. (Pubitemid 350002834)
13. Zhang P, Pan W, Rux AH, Sachais BS, Zheng XL. The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow. Blood. 2007;110:1887-1894. (Pubitemid 47443901)
14. Banno F, Kaminaka K, Soejima K, Kokame K, Miyata T. Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease. J Biol Chem. 2004;279:30896-30903. (Pubitemid 38938026)
15. Zhou W, Bouhassira EE, Tsai HM. An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers. Blood. 2007;110:886-893. (Pubitemid 47267425)
16. Banno F, Miyata T. Biology of an antithrombotic factor-ADAMTS13. In: Tanaka K, Davie EW, eds. Recent Advances in Thrombosis and Hemostasis. Berlin, Germany: Springer; 2008:162-176.
17. Banno F, Kokame K, Okuda T, et al. Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Blood. 2006;107:3161-3166.
18. Miyata T, Kokame K, Banno F, Shin Y, Akiyama M. ADAMTS13 assays and ADAMTS13-deficient mice. Curr Opin Hematol. 2007;14:277-283.
19. Kokame K, Matsumoto M, Fujimura Y, Miyata T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood. 2004;103:607-612. (Pubitemid 38140094)
20. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005;129:93-100. (Pubitemid 40524057)
21. Tsuji S, Sugimoto M, Miyata S, Kuwahara M, Kinoshita S, Yoshioka A. Real-time analysis of mural thrombus formation in various platelet aggregation disorders: distinct shear-dependent roles of platelet receptors and adhesive proteins under flow. Blood. 1999;94:968-975. (Pubitemid 29361828)
22. Chauhan AK, Motto DG, Lamb CB, et al. Systemic antithrombotic effects of ADAMTS13. J Exp Med. 2006;203:767-776.
23. Ni H, Denis CV, Subbarao S, et al. Persistence of platelet thrombus formation in arterioles of mice lacking both von Willebrand factor and fibrinogen. J Clin Invest. 2000;106:385-392. (Pubitemid 30655638)
24. Frenette PS, Moyna C, Hartwell DW, Lowe JB, Hynes RO, Wagner DD. Platelet-endothelial interactions in inflamed mesenteric venules. Blood. 1998;91:1318-1324. (Pubitemid 28086885)
25. DiMinno G, Silver MJ. Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol. J Pharmacol Exp Ther. 1983;225:57-60. (Pubitemid 13137003)
26. Jackson SP. The growing complexity of platelet aggregation. Blood. 2007;109:5087-5095.
27. Konstantinides S, Ware J, Marchese P, Almus-Jacobs F, Loskutoff DJ, Ruggeri ZM. Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis. J Thromb Haemost. 2006;4:2014-2021. (Pubitemid 44226783)
28. Shida Y, Nishio K, Sugimoto M, et al. Functional imaging of shear-dependent activity of ADAMTS13 in regulating mural thrombus growth under whole blood flow conditions. Blood. 2008;111:1295-1298. (Pubitemid 351213413)
29. Smyth SS, Reis ED, Vaananen H, Zhang W, Coller BS. Variable protection of beta 3-integrin-deficient mice from thrombosis initiated by different mechanisms. Blood. 2001;98:1055-1062.
30. Cui J, Eitzman DT, Westrick RJ, et al. Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood. 2000;96:4222-4226.
31. Weiler H, Lindner V, Kerlin B, et al. Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol. 2001;21:1531-1537. (Pubitemid 34219820)
32. Suh TT, Holmback K, Jensen NJ, et al. Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice. Genes Dev. 1995;9:2020-2033.
33. Toomey JR, Kratzer KE, Lasky NM, Broze GJ Jr. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci U S A. 1997;94:6922-6926.
34. Motto DG, Chauhan AK, Zhu G, et al. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest. 2005;115:2752-2761. (Pubitemid 41434402)
35. Nishio K, Anderson PJ, Zheng XL, Sadler JE. Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13. Proc Natl Acad Sci U S A. 2004;101:10578-10583. (Pubitemid 38955784)
36. Shim K, Anderson PJ, Tuley EA, Wiswall E, Sadler JE. Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress. Blood. 2008;111:651-657.
37. Donadelli R, Orje JN, Capoferri C, Remuzzi G, Ruggeri ZM. Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood. Blood. 2006;107:1943-1950. (Pubitemid 43289375)
38. Chauhan AK, Walsh MT, Zhu G, Ginsburg D, Wagner DD, Motto DG. The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis. Blood. 2008;111:3452-3457.